Author： Kersten G.F.A. Crommelin D.J.A.
Publisher： Elsevier
ISSN： 0264-410X
Source： Vaccine, Vol.21, Iss.9, 2003-02, pp. : 915-920
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
ISCOMs vaccine against experimental leishmaniasis
By Papadopoulou G. Karagouni E. Dotsika E.
Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. :
Access to resources
Recommend
Cytotoxic T cell polyepitope vaccines delivered by ISCOMs
By Le T.T.T. Drane D. Malliaros J. Cox J.C. Rothel L. Pearse M. Woodberry T. Gardner J. Suhrbier A.
Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. :
By Rahimpour Yahya Hamishehkar Hamed
Expert Opinion on Drug Delivery, Vol. 9, Iss. 4, 2012-04 ,pp. :
Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant
By Bengtsson K.L. Sjolander A.
Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. :